详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

National screening programs for cervical cancer in Asian countries.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Preventive Medicine Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan [2]Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China [3]Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Beijing, China [4]Department of Gynecology, All India Institute of medical Sciences, New Delhi, India [5]Department of Obstetrics and Gynecology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Jakarta, Indonesia [6]Division of Medical Support and Partnership, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan [7]National Cancer Control Institute, National Cancer Center, Goyang, Korea [8]Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea [9]Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

出处：

DOI：

ISSN：

关键词： Cervical Cancer Cancer Screening National Health Programs Asia

摘要：

Cervical cancer is still one of the most common female cancers in Asia and the leading cause of cancer-related deaths in low- and middle-income countries. Nowadays, national screening programs for cervical cancer are widely provided in Asian countries. We reviewed the National Cancer Screening Program (NCSP) in China, India, Indonesia, Japan, Korea, and Thailand. The NCSP were established at varying times, from 1962 in Japan to 2014 in Indonesia. The primary screening method is based on cytology in all countries except for India and Indonesia. In India and Indonesia, visual inspection of the cervix with acetic acid (VIA) is mainly used as a primary screening method, and a "see and treat" strategy is applied to women with a positive VIA result. The starting age of NCSP ranges from 18 years in China to 30 years in Thailand. The screening interval is 2 years in all countries except for China and Indonesia, in which it is 3 years. Uptake rates of NCSP vary from 5.0%-59.7%. Many women in low- and middle-income countries still do not participate in NCSP. To improve uptake rates and thereby prevent more cases of cervical cancer, Asian countries should continue to promote NCSP to the public using various approaches. Copyright © 2020. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 2 区医学

小类 | 2 区妇产科学 3 区肿瘤学

最新[2023]版：

大类 | 2 区医学

小类 | 2 区妇产科学 2 区肿瘤学

第一作者：

第一作者机构： [1]Department of Preventive Medicine Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan

通讯作者：

通讯机构： [8]Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea [*1]Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, 566 Nonhyeon-ro, Gangnam-gu, Seoul 06135, Korea.

推荐引用方式(GB/T 7714)：

APA：

MLA：

National screening programs for cervical cancer in Asian countries.

文献详情

相关文献